Skip to main content

Table 1 Correlation of miR-924 with clinicopathological features of patients with non-small cell lung cancer

From: MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway

miR-924 expression

Variable

Total (n = 79)

High (n = 34)

Low (n = 45)

P value

Gender

   

1.012

 Male

62

26

36

 

 Female

17

8

9

 

Age (year)

   

0.589

 < 60

45

13

32

 

 ≥ 60

34

21

13

 

Smoking history

   

0.485

 Yes

51

24

27

 

 No

28

10

18

 

Tumor size (cm)

   

0.063

 < 4

28

17

11

 

 ≥ 4

51

17

34

 

TNM stage

   

0.003

 I + II

66

30

36

 

 III + IV

13

4

9

 

Lymphatic metastasis

   

0.016

 Yes

28

7

21

 

 No

51

27

24

 

Pathological type

   

0.886

 Adenocarcinoma

36

15

21

 

 Squamous carcinoma

43

19

24

 
  1. The italic values indicates the P values which are less than 0.05